Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{177517,
        author = {PURMA SHARANYA},
        title = {POSTPARTUM DEPRESSION},
        journal = {International Journal of Innovative Research in Technology},
        year = {2025},
        volume = {11},
        number = {12},
        pages = {2357-2362},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=177517},
        abstract = {Postpartum depression (PPD) is a significant mental health concern affecting approximately 10–20% of new mothers worldwide. It is characterized by persistent sadness, anxiety, fatigue, and impaired mother-infant bonding, potentially impacting both maternal well-being and child development. This review explores the epidemiology, risk factors, pathophysiology, diagnosis, and treatment options for PPD. Biological factors such as hormonal fluctuations, genetic predisposition, and inflammation, along with psychosocial stressors, contribute to its onset. Early screening and intervention, including psychotherapy, pharmacotherapy, and lifestyle modifications, are crucial for effective management. Future research should focus on personalized treatment strategies and addressing healthcare disparities to improve outcomes.},
        keywords = {Terms: Depression, Postpartum Depression (PPD), DSM-5 Diagnostic Criteria, Cognitive Behavioral Therapy (CBT), Selective Serotonin Reuptake Inhibitors (SSRIs).},
        month = {May},
        }